The Global Market for Immunochemicals (Research Antibodies) is Projected to Reach US$5.1 Billion by 2024
Rising Government Funding
and Increasing R&D Initiatives Drive the Global Immunochemicals Market, According
to a New Report by Global Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market size, share and demand forecasts on the global Immunochemicals market. The global market for Immunochemicals
(Research Antibodies) is projected to reach US$5.1 billion by 2024, driven by increasing
R&D initiatives in the life sciences sector, rising government funding for
proteomics research and drug discovery and growing collaborations between
academic institutes and industries.
The
global market for immunochemicals for research is set to witness rapid growth,
driven by increasing R&D initiatives in the life sciences sector, rising
government funding for proteomics research and drug discovery, and increasing
collaborations between academic institutes and industries. Antibodies
constitute critical constituents of numerous research methodologies, including
protein and antibody micro arrays, cell-based immunoassays, and protein
electrophoresis. Significant growth opportunities are also available for
detecting antibody interactions, particularly for chemiluminescent, fluorescent, and
radioactive probes. Further, antibodies are also used extensively for drug
delivery, imaging, therapeutics, and diagnostics, as well as finding
application as assay components, and research tools. The critical role of
antibodies in the field of drug discovery and research is attributed to their
vast diversity, as well as their ability to exhibit high specificity in
antibody-antigen interactions. Such characteristics are highly beneficial in
unraveling details of various biological systems. The high significance of
antibodies is primarily attributed to their ability to identify and isolate
proteins, which holds enormous importance in the field of proteomics.
Continuous rise in the
number of suppliers as well as the availability of a broad range of antibodies
has been favoring growth in the catalogue antibody market. However, the
scenario is changing with the advent of proteomics and the identification of
newer targets, which in turn is fostering the demand for custom antibodies.
Genome projects and proteome research are creating growth opportunities for custom antibodies by facilitating discovery of novel proteins, thereby encouraging manufacturers to augment and revamp their stocks
with novel antibodies. The preference for custom antibodies continues to
grow, despite their higher price in comparison to catalogue antibodies.
Rising
number of cancer cases is leading to rising demand for cancer research, in turn
driving the cancer research antibodies market. Key cancer research areas
include metastasis, apoptosis, autophagy, tumor suppressors, metabolism, proliferative
signaling, inflammation, among others. Research antibodies are increasingly
being used as tools in several applications, such as measuring enzymes
activity, profiling proteins, signaling pathways, identifying candidate
biomarkers, and measuring the expression levels or modifications of
cancer-related proteins.
As
stated by the new market research report on Immunochemicals, the U.S. represents the
largest market worldwide, backed by the increase in NIH funding. Asia-Pacific ranks
as the fastest growing market worldwide with a CAGR of 13.9% through the
analysis period. China is expected to spearhead growth in the region supported
by the increased investments in research and development. Active government
support for biotechnology research and emergence of India and China as major
centers of clinical research are also favoring the growth of immunochemicals
market in the region.
Major
players in the market include Abcam Plc., Agilent Research Laboratories,
Beckman Coulter GmbH, Biolegend Inc., Bio-Rad Laboratories Inc., Cell Signaling
Technology Inc., GenScript Biotech Corporation, PerkinElmer Inc., Rockland
Immunochemicals Inc., Santa Cruz Biotechnology Inc., Merck (Sigma-Aldrich
Corporation), and Thermo Fisher Scientific Inc., among others..
The
research report titled “Immunochemicals: A Global
Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market
trends, issues, drivers, mergers, acquisitions and other strategic industry
activities of global companies. The report provides market estimates and
projections in value terms for all major geographic markets such as United
States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and
Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), Latin America and
Rest of World. Segments analyzed include Catalog Antibodies and Custom
Antibodies.
Global
Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights
Reserved.
Comments
Post a Comment